New guidance documents to enhance health product research and development published
Health workforce migration: Expert Advisory Group meets in Geneva
Medical Product Alert N°2/2024: Falsified OZEMPIC (semaglutide)
WHO issues warning on falsified medicines used for diabetes treatment and weight loss
Update on the Guideline Development Group on the health of trans and gender diverse people
Chad eliminates human African trypanosomiasis as a public health problem
Go.Data transition to an open-source tool
WHO and United States Food and Drug Administration extend the CRP-Lite pilot
